Neurodegenerative disorders, such as Alzheimer's disease (AD), is associated with the loss of neuronal cells, and it has been suggested that apoptosis is a crucial pathway in neuronal loss in AD patients. Recent evidence suggests that amyloid beta peptide (Ab) induces neuronal apoptosis in the brain and in primary neuronal cultures. In this study, we investigated the impact of b-asarone against the apoptosis induced by Ab in rat hippocampus. The results showed that intrahippocampal injections of Ab (1 42) caused apoptosis in rat hippocampus. Oral administration of b-asarone (12.5, 25, or 50 mg/kg) for 28 d reverse the increase in the number of terminal deoxynucleotidyl transferase dUTP nickend labeling positive cells in the hippocampus tissue. Mitochondrial dysfunction is a hallmark of b-amyloid (Ab)-induced neuronal toxicity in AD. Therefore, we investigated nuclear translocation of apoptosis induction factors. Our results showed that b-asarone aŠorded a beneˆcial inhibition on both mRNA and protein expression of Bad, Bax, and cleavage of caspases 9 in rat hippocampus following intrahippocampal injections of Ab (1 42). Our further investigation revealed that ASK1, p-MKK7, and p-c-Jun were signiˆcantly decreased after b-asarone treatment, implicating that the modulation of ASK1/c-JNK-mediated intracellular signaling cascades might be involved in therapeutic eŠect of basarone against Ab toxicity. Taken together, these results suggest that b-asarone may be a potential candidate for development as a therapeutic agent for AD.
INTRODUCTION
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases and the most frequent cause of dementia in the elderly. 1) However, the cause of AD is still unknown and the treatment is therefore only palliative. AD is characterized by the presence of amyloid plaques in speciˆc areas of the brain, 2) andˆnally by the atrophy of the aŠected brain regions, which results from extensive losses of synapses and neurons. 3) Recent studies have shown that in AD brains and in cultures of neurons exposed to Ab, the dying cells display the characteristics of apoptosis. 4 5) The role of apoptosis in Ab-induced toxicity suggests that its modulation may slow the neurodegenerative process.
Mitogen-activated protein kinases (MAPK) are essential components of eukaryotic signal transduction networks that enable cells to respond appropriately to extracellular signals and stresses. 6) MAPK is activated by sequential protein phosphorylation through a MAPK module. In the case of the c-Jun N-terminal kinase (JNK) cascade, apoptosis-signal-regulating kinase (ASK) 1 is a mitogen-activated protein kinase kinase kinase (MAPKKK) that activates MAP kinase kinase (MKK) 7, which in turn activates JNK, a member of MAPK. 7) The MAPK signal transduction cascade plays pivotal roles in many cellular processes including cell growth, diŠerentiation, and apoptosis. 8) It has also been demonstrated that the JNK/c-Jun pathway is hyperactive in the AD brain. 9) ASK1 activation is a key mechanism in Ab-induced neurotoxicity, which plays a central role in Alzheimer's disease. 10) The acetylcholinesterase inhibitors, 11) such as donepezil, antioxidants such as vitamin E, 12) and inhibitors to NMDA excitotoxicity 13) are clinically used in AD therapy, because they marginally delay disease progression. However, currently there is no curative therapy for AD. 14) Acorus tatarinowii Schott has been found to be eŠective in the management of amnesia. 15) b-asarone (for its structure, see Fig. 1 ), and the major ingredient of Acorus tatarinowii Schott, might be a very promising drug to treat neurodegeneration disorders, including AD.
Because apoptosis inhibitors can prevent cell death even in the continued presence of the apoptosis-inducing trigger, apoptosis pathways are attractive tar- gets for therapeutic intervention. 16) So far, whether basarone might be beneˆcial to AD by suppressing the apoptosis still remains to be elucidated. The aims of this study were, therefore, to investigate the eŠect of b-asarone on the Ab-induced neuronal apoptosis and to identify signaling protein kinase cascades that may be responsible for the putative eŠect of b-asarone.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley (SD) rats (weight range: 220 to 240 g) were purchased from the Beijing Vital River Experimental Animals Technology Ltd. (Beijing, China), and were housed 6 per cage in a light-controlled room (lights on from 7:00 AM to 7:00 PM) at a temperature of 22±2°C and humidity of 50±5％ with food and water ad libitum feeding. All studies were previously approved by the Animal Care and Use Committee of Qiqihar Medical University. Rats were assigned randomly into 7 groups: the normal control group, sham control group, the Abinjection group, Ab plus donepezil group, Ab plus basarone (12.5 mg/kg) group, Ab plus b-asarone (25 mg/kg) group, and Ab plus b-asarone (50 mg/kg) group.
Ab(1 42)-induced AD Rat Model
The Ab (1 42) (Sigma, St. Louis, MO. USA) were dissolved in 35％ acetonitrile/0.1％ tri‰uoroacetic acid at a concentration of 10 mg/ml and incubated at 37°C for 7 d to allow forˆbril formation. The rats were anesthetized with sodium pentobarbital (40 mg/kg, i.p.), and placed on a stereotaxic instrument (David Kopf Instruments, Tujunga, CA). The scalp of each rat was incised, and the skull was adjusted to place bregma and lambda on the same horizontal plane. Small burr holes were drilled and Ab (1 42) (1 ml＝10 mg) or the vehicle (1 ml) were injected into the bilateral hippocampuses (-3.0 mm anteroposterior,±2.2 mm medial-lateral, -2.8 mm dorsal-ventral from the dura, according to bregma) 17) at a rate of 0.2 ml/min with a 5 ml Hamilton syringe with 27-gauge stainless steel needle. The hole was blocked with dental acrylic cement and scalp was then closed with suture. Sham group rats received the same surgical procedures with injection of identical volume vehicle (acetonitrile/0.1 ％ tri‰uoroacetic acid). After wound sutured, the rats were allowed to recover from surgery for 3 days. Donepezil hydrochloride (0.33 mg/kg) (Sigma, St. Louis, MO. USA) (referred to simply as donepezil) and b-asarone (Sigma, St. Louis, MO. USA) (12.5, 25, or 50 mg/kg) were administered intragastricly once daily for 28 days from three days after Ab (1 42) hippocampus injection.
Tissue Processing Rats were anesthetized and transcardially perfusion-ˆxed with 4％ formaldehyde in 0.1 M sodium phosphate buŠer (pH 7.4). Brains were removed quickly and postˆxed with the sameˆx-ation solution overnight at 4°C. Postˆxeds brain were embedded in papa‹n, and 5-micrometer sections were obtained using a rotary microtome and placed on pretreated slides.
Evaluation of Apoptosis with Terminal Deoxynucleotidyl Transferase-mediated dUTP Nick-end Labeling (TUNEL) Staining
For detection of in situ DNA fragmentation, TUNEL staining was performed using an TACSR TdT In Situ Apoptosis Detection Kits (Trevigen Inc., Gaithersburg, Md., USA) according to the manufacturer's protocol. In brief, tissue sections were treated with 3％ hydrogen peroxide to quench endogenous peroxidase activity. After adding the equilibration buŠer, sections were treated with terminal deoxynucleotidyltransferase (TdT) and digoxigenin-dNTPs for 60 min at 37°C. Specimens were then treated with anti-digoxigeninperoxidase for 30 min at 37°C, colorized with 3,3′ -diaminobenzidine (DAB) substrate. Finally, slides were rinsed, dehydrated, and mounted. A negative control was prepared by omitting the TdT enzyme to control for non-speciˆc incorporation of nucleotides or binding of enzyme-conjugate. The specimens were examined using a bright-ˆeld microscope (Zeiss Axioskop; Carl Zeiss GmbH, Jena, Germany) and the data expressed as the number of TUNEL-positive cells/mm 2 in at leastˆve random high-powerˆelds.
RNA Isolation and Real-time PCR Total RNA was extracted from 100 mg of frozen hippocampus tissues using RNAiso Reagent kit (Takara Biotechnology, Dalian, China), and cDNA was synthesized with SYBR ExScript TM RT-PCR kit (Takara Biotechnology, Dalian, China) according to the manufacturer's protocol. Reverse transcription was carried out as follows: 42°C for 15 min, 95°C for 2 min (one cycle). cDNA stored at -20°C for PCR.
Real-time PCR was performed in a 50 ml of reaction solution. The following sequences were used as primers: ASK1 sense primer, 5′ -CTG TGC TAA TGA CCT GCT TGT TG -3′ , and ASK1 antisense primer, 5′ -TAC CCG AGA GTT TGG GCT GT; MKK7 sense primer, 5′ -GGC TCC CGT CAA CCT TGT TC-3′ , and MKK7 antisense primer, 5′ -GGT ACC CTG TCT GCT TCA TGA TCT C; c-Jun sense primer, 5′ -GGG AAC AGG TGG CAC AGC TTA-3′ , and c-Jun antisense primer, 5′ -GCA ACT GCT GCG TTA GCA TGA; Bad sense primer, 5′ -ACA CGC CCT AGG CTT GAG GA-3′ , and Bad antisense primer, 5′ -GGC TCA AAC TCT GGG ATC TGG A; Bax sense primer, 5′ -AGA CAC CTG AGC TGA CCT TGG AG-3′ , and Bax antisense primer, 5′ -GTT GAA GTT GCC ATC AGC AAA CA; caspase-9 sense primer, 5′ -CTG AGC CAG ATG CTG TCC CAT A-3′ , and caspase-9 antisense primer, 5′ -CCA AGG TCT CGA TGT ACC AGG AA; GAPDH sense primer, 5′ -GAC AAC TTT GGC ATC GTG GA -3′ , and glyceraldehyde phosphate dehydrogenase (GAPDH) antisense primer, 5′ -ATG CAG GGA TGA TGT TCT GG. The thermal proˆle was as follows: 1 cycle of 95°C for 10 s; 40 cycles of 5 s at 95°C and 31 s at 60°C. Reactions were performed in a ABI7300 real-time PCR system (Applied Biosystems, CA), and threshold cycle (Ct) data were collected using the Sequence Detection Software version 1.2.3 (Applied Biosystems, CA).
Real-time PCR assay was performed in triplicate for each samples to ensure reproducibility. The relative quantiˆcation of gene expression was analysed by the 2 -DDCt method. 18) The fold change in target gene cDNA relative to the GAPDH internal control was determined by:
Fold change＝2
, where DDCt＝(Ct target gene
Cytoplasm proteins were isolated from 120 mg of frozen hippocampus tissues using Cytoplasmic Protein Extraction kit (Beyotime Biotechnology, Haimen, China), and protein concentrations were determined using the BCA Protein Assay kit (Beyotime Biotechnology, Haimen, China) according to the protocol provided by the manufacturer, then they were aliquoted and stored.
100 ml of supernatant was added to an equal volume of 2×SDS sample buŠer and boiled for 5 min at 100°C. The samples were then stored at -80°C until analyzed. (SD) and n represents the number of rats used in each experiment. The one way analysis of variance (ANO-VA) was used to evaluate the diŠerence among multiple groups followed by a post hoc test (Student-Newman-Keuls). The data were analyzed by SPSS 13.0 software (SPSS Inc., Chicago, IL, USA), and p＜ 0.05 was assessed as statistically signiˆcant.
RESULTS
b-Asarone Attenuates Neuronal Apoptosis in an Ab (1 42)-injected AD Rat Model
To explore the eŠects of b-asarone on apoptosis induced by Ab (1 42), TUNEL staining was used to identify apoptotic cells in the hippocampus. Control sections incubated without TdT enzyme showed no staining (results not shown). Brain sections from the sham and normal group showed very few TUNEL-positive nuclei, whereas there was an increase in TUNEL-positive ＋b-asarone (12.5, 25, or 50 mg/kg) group (Fig. 2  (A) ). (Fig. 3(A) and (B) ). Consistent with the results of protein levels, real-time PCR revealed that b-asarone treatment (12.5, 25, or 50 mg/kg) signiˆcantly decreased Bax mRNA levels to 2.56±0.67, 2.48±0.44, and 2.04±0.45 from 4.37±1.19 of Abinjected rats, and decreased Bad mRNA levels to 3.03 ±0.39, 2.85±0.51, and 3.02±0.58 from 5.56±1.08 (Fig. 3(C) ). In addition, up-regulation of Bax and Bad was not attenuated by donepezil.
Involvement of Caspase-9 Activition in the Suppressive EŠect of b-Asarone against Ab (1 42)-induced Neuronal Apoptosis Caspase-9, a key molecule in apoptotic signaling, is thought to be initiator caspases. To determine whether b-asarone suppresses neuronal apoptosis in rat hippocampus in- (Fig. 4(A) and (B) ). Consistent with the results of protein levels, real-time PCR result revealed that b-asarone treatment (50 mg/kg) signiˆcantly reduced caspase-9 mRNA levels to 1.38±0.27 from 1.83±0.26 of Ab-injected rats (Fig. 4(C) ).
EŠect of b-Asarone Attenuation Ab (1 42)-induced Neuronal Apoptosis through a ASK1/c-Jun Signal Pathway
To determine whether the ASK1/ c-Jun pathway functions involvement in that b-asarone attenuate Ab (1 42)-induced neuronal apoptosis, we assessed mRNA and protein of ASK1, p-MKK7, and p-c-Jun using western blot and real-time PCR analysis, respectively. Western blotting result revealed that ASK1, p-MKK7, and p-c-Jun protein was clearly up-regulated in Ab-induced hippocampus in comparison with that sham-operated hippocampus. However, the expression of ASK1, p-MKK7, and p-c-Jun in Ab-induced hippocampus was signiˆcantly down-regulated when the rats were treated with b-asarone (12.5, 25 or 50 mg/kg) (Figs. 5(A) and (B), 6 (A) and (B), 7(A) and (B)). Donepezil (0.33 mg/ kg) had no eŠect on those proteins expression. Realtime PCR result revealed that ASK1 and MKK7 mRNA expression in hippocampus tissues was signiˆcantly deceased when rats were treated with b-asarone compared with control (Figs. 5(C) and 6(C)), but mRNA expression of c-Jun was not altered signiˆcantly (Fig. 7(C) ).
DISCUSSION
We have clearly demonstrated for theˆrst time in the current study that b-asarone treatment attenuated neuronal apoptosis induced by intrahippocampal injection of Ab (1 42). b-asarone aŠorded a beneˆcial inhibition on expression of Bad, Bax, and cleavage of caspases 9 in rat hippocampus following intrahippocampal injections of Ab (1 42). In addition, the modulation of ASK1/c-Jun-mediated intracellular Treatment with b-asarone (12.5, 25, or 50 mg/kg) or donepezil (0.33 mg/kg) given p.o. was initiated 3 days after the Ab (1 42) intrahippocampal injections into SD rat for 28 days. A) Procaspase-3 and cleaved caspase-9 levels were determined by western blot analysis wth antibody to caspase-9. The loading of the lanes was normalized to levels of GAPDH. B) Quantitated results of activated caspase-9 are presented relative to sham. Densitometric analysis of western blot obtained from 5 rats per group. C) Total RNA was isolated from hippocampus using RNAiso reagent and used for cDNA synthesis. The mRNA levels of caspase-9 were detected by real-time PCR. 2 -DDCt analysis of PCR obtained from 5 rats per group, and data are expressed as means±S.D.;  p＜0.05, § p＜0.05, vs. Ab (1 42)-injected rats. Treatment with b-asarone (12.5, 25, or 50 mg/kg) or donepezil (0.33 mg/kg) given p.o. was initiated 3 days after the Ab (1 42) intrahippocampal injections into SD rat for 28 days. A) ASK1 levels were determined by western blot analysis wth antibody to ASK1. The loading of the lanes was normalized to levels of GAPDH. B) Quantitated results of ASK1 are presented relative to sham. Densitometric analysis of western blot obtained from 5 rats per group. C) Total RNA was isolated from hippocampus using RNAiso reagent and used for cDNA synthesis. The mRNA levels of ASK1 were detected by real-time PCR. 2 -DDCt analysis of PCR obtained from 5 rats per group, and data are expressed as means±S.D.;  p＜0.05, § p＜0.05, vs. Ab (1 42)-injected rats.
signaling cascades might be involved in therapeutic eŠect of b-asarone against Ab toxicity.
Acorus tatarinowii Schott has long been employed in the clinical treatment of AD in Chinese herbal books. It has been reported to be responsible for vari- Treatment with b-asarone (12.5, 25, or 50 mg/kg) or donepezil (0.33 mg/kg) given p.o. was initiated 3 days after the Ab (1 42) intrahippocampal injections into SD rat for 28 days. A) MKK7 and P-MKK7 levels were determined by western blot analysis wth antibodies to MKK7 and p-MKK7. The loading of the lanes was normalized to levels of GAPDH. B) Quantitated results of p-MKK7 are presented relative to sham. Densitometric analysis of western blot obtained from 5 rats per group. C) Total RNA was isolated from hippocampus using RNAiso reagent and used for cDNA synthesis. The mRNA levels of MKK7 were detected by real-time PCR. 2 -DDCt analysis of PCR obtained from 5 rats per group, and data are expressed as means± S.D.;  p＜0.05, § p＜0.05, vs. Ab (1 42)-injected rats. Apoptosis is a fundamental process of cell death that occurs via activation of distinct signaling pathways involving mitochondria, mitochondrial regulatory proteins, and activation of caspases. 21) Ultimately, cells undergo nuclear chromatin condensation, DNA fragmentation, and formation of apoptotic bodies. Several studies presently indicate that apoptosis selectively increased in primary neuronal cultures exposed to Ab and also augmented in brain tissue derived from AD patients. 22) Caspase-9 belongs to a large family of cellular cystine proteases, known collectively as caspases for their preferential ability to cleave cellular substrates after aspartic acid residues. 23) The cleavage of caspase-speciˆc substrates results in the biochemical destruction of the cell and phenotypic changes associated with apoptosis. 24) Caspase-9 is thought to be initiator caspases. 25) In the present study, we used TUNEL staining to identify apoptotic cells in the hippocampus. Brain sections from the sham group showed very few TUNEL-positive nuclei, whereas there was an increase in TUNEL-positive cells in the Ab hippocampus injection group. The increase in TUNEL-positive cells was inhibited after administration of b-asarone for 28 days. We further determined the activation of caspase-9 and show Ab hippocampus injection increased the level of cleaved caspase-9, marker for caspase-9 activity, which is the feature of apoptosis in AD. Beta-asarone treatment attenuated the expression of activated caspase-9 induced by Ab in the hippocampus in a dose-dependent manner.
Many components of the mitochondrial apoptotic cascade appear to be involved in the neuronal toxicity of Ab peptides. 26) Ab can upregulate pro-apoptotic Bax expression or require Bax to mediate neurotoxicity. 27) In addition, Bax protein levels have been reported to be increased in AD brain. 28) Another proapoptotic protein Bad is located in the cytosol but translocate to the mitochondria and form a proapoptotic complex with Bcl-2. 29) Bad and Bax have been reported to directly inhibit members of the caspase family, including caspases-9 which is a potent eŠector of neuronal death among the identiˆed caspases. 30) In the present study, we observed that Ab-induced apoptosis are characterized by increased expression of the proapoptotic Bax and Bad. Furthermore, Ab-injected rats treated with b-asarone exhibited descent of proapoptotic protein Bax and Bad. These results suggested that the mitochondrial pathway of cell death might be involved in therapeutic eŠect of b-asarone against Ab toxicity. Our results are in agreement with previousˆndings reported by Sol áa et al. in cortical neurons. 31) ASK1 is a ubiquitously expressed MAPKKK that activates the JNK and p38 pathways by directly phosphorylating and thereby activating their respective MAPKK7 and MAPKK4. 32) Overexpression of wildtype or constitutively active ASK1 induces apoptosis in various cells through mitochondria-dependent caspase activation. 33) ASK1 is present in neuronal cells and has been implicated in various types of neuronal cell death. 34) JNK and c-Jun are directly activated by the dual speciˆcity MAP kinase kinases MKK4 and MKK7. The organization of the JNK/c-Jun signaling pathway is similar to that of other mammalian MAPK modules. 35) The extracellular signal-regulated kinase (ERK) group of MAPK is activated by MKK1 /MKK2 and p38 group of MAPK is activated by MKK3/MKK6. 36) In vitro assays demonstrate that MKK4 can activate both JNK and p38 MAPK. In contrast, MKK7 selectively activates only JNK. 37) Concerted actions of molecular signaling networks determine cell fates. In the many stress-responsive signaling pathways, JNK/c-Jun signaling cascade is crucial for the maintenance of cell homeostasis and controls many cellular processes, including cell growth, transformation, diŠerentiation and apoptosis. 38) There is very strong evidence linking the activation of JNK to neuronal loss in response to Ab neurotoxicity. 39 ) JNK/c-Jun signaling promotes apoptosis that is linked to transcriptional regulation of many genes, including Bad and Bax. 40) SP600125, JNK pharmacological inhibitor, eŠectively prevents Ab-induced alterations of Bcl-2 family expression during apoptosis, indicating that this critical step in the Ab inducedapoptosis pathway is dependent on JNK activation. 41) Thus, the suppression of c-Jun-dependent apoptosis gene expression may be an extremely eŠective therapeutic strategy for preventing neuronal cell apoptosis. In the present study, we observed that b-asarone signiˆcantly attenuated Ab-induced changes in Bad and Bax expression. Notably, it also signiˆcantly reduced Ab-induced c-Jun phosphorylation, suggesting that b-asarone attenuation of As-induced changes in Bad and Bax expression is linked to JNK/c-Jun pathway in rat hippocampus. Theseˆndings are con-sistent with previous data from the literature indicating that c-Jun represents a key target of various neuroprotective agent, including estrogen. 41) In conclusion, our results are consistent with the hypothesis that b-asarone potentially attenuate neuronal apoptosis in rats induced by Ab (1 42) when taken orally. The attenuation is associated with the inhibition of p-c-Jun activation, Bad expression, Bax expression, and activation of caspase-9. Ourˆndings suggest that b-asarone, an important active principal of Acorus tatarinowii Schott, might be a potential drug for the AD to suppress AD-related neuronal cell apoptosis.
